Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F-18 THK-5351 PET in Alzheimer's Disease
NCT02686216Phase 1Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Dec 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of 18F-THK5351 in Alzheimer's disease (AD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Dosimetry of F-18 THK-5351 at 1 year. Started Dec 2015; status: completed.
02
Drugs
18F-THK5351
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02686216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686216.